| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | -2.59% | -0.03% | -2.56% | -2.56% | — |
| 14d | 2 | +100.00% | +0.82% | +1.46% | -0.64% | -0.64% | — |
| 30d | 2 | +100.00% | +5.64% | +2.41% | +3.23% | +3.23% | — |
| 60d | 2 | +100.00% | +18.35% | +3.01% | +15.34% | +15.34% | — |
| 90d | 2 | +100.00% | +24.68% | +4.10% | +20.59% | +20.59% | — |
| 180d | 2(1 pending) | +100.00% | +59.54% | +15.17% | +44.37% | +44.37% | — |
| 1y | 2(1 pending) | +100.00% | +59.77% | +24.25% | +35.52% | +35.52% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE10b5-1 10b5-1 plan | 90,000 | $8.03 | $722.5K | 1,691,126 | Jul 1, 2026 | Jul 2, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | PURCHASE See Remarks | 4 | $3.94 | $16 | 1,777,725 | Mar 12, 2026 | Mar 16, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 4 | $3.94 | $16 | 79,996 | Mar 12, 2026 | Mar 16, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | PURCHASE See Remarks | 48,894 | $4.09 | $200.0K | 1,777,721 | Mar 12, 2026 | Mar 16, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 48,894 | $4.09 | $200.0K | 43,773 | Mar 12, 2026 | Mar 16, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 30,289 | $7.36 | $222.9K | 1,755,146 | Jan 31, 2026 | Feb 2, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 68,454 | $7.36 | $503.8K | 1,785,435 | Jan 31, 2026 | Feb 2, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 27,319 | $7.36 | $201.1K | 1,727,827 | Jan 31, 2026 | Feb 2, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | PURCHASEGRANT Stock grant | 168,463 | — | — | 1,853,889 | Jan 30, 2026 | Feb 2, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | PURCHASEGRANT Stock grant | 225,225 | — | — | 225,225 | Jan 30, 2026 | Feb 2, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE10b5-1 10b5-1 plan | 15,000 | $8.00 | $120.0K | 1,685,426 | Jan 8, 2026 | Jan 9, 2026 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 733 | $8.31 | $6.1K | 1,700,426 | Oct 2, 2025 | Oct 3, 2025 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 2,000 | — | — | 0 | Sep 11, 2025 | Sep 15, 2025 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 14,651 | $5.38 | $78.8K | 1,701,159 | Aug 1, 2025 | Aug 4, 2025 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | PURCHASE See Remarks | 25,000 | $4.38 | $109.5K | 1,708,585 | Jun 13, 2025 | Jun 16, 2025 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 733 | $5.15 | $3.8K | 1,683,585 | Apr 2, 2025 | Apr 3, 2025 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | PURCHASEGRANT Stock grant | 185,000 | — | — | 1,684,318 | Jan 31, 2025 | Feb 3, 2025 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | PURCHASEGRANT Stock grant | 500,000 | — | — | 500,000 | Jan 31, 2025 | Feb 3, 2025 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 48,834 | $3.56 | $173.8K | 1,499,318 | Jan 31, 2025 | Feb 3, 2025 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 29,300 | $3.56 | $104.3K | 1,548,152 | Jan 31, 2025 | Feb 3, 2025 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | SALE See Remarks | 24,501 | $3.61 | $88.4K | 1,577,452 | Jan 3, 2025 | Jan 7, 2025 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Aug 1, 2024 | Aug 2, 2024 ↗ | View → |
| XERS XERIS BIOPHARMA HOLDINGS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 1,601,953 | Aug 1, 2024 | Aug 2, 2024 ↗ | View → |